Skip to content
Screener

TransMedics Group, Inc. TMDX Q4 2025 Annual earnings

Reported February 24, 2026 · After market close

Revenue$160.8MBeat by $5.4M
EPS$0.57Beat by $0.16
Revenue estimate$155.4M
EPS estimate$0.41

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$177.5M
EPS estimate$0.30

Financials

Q4 2025

Income statement

See full
Revenue$160.8M+32.2%
Gross profit$93.4M+29.7%
Operating income$21.3M+146%
Net income$105.4M+1,437%
EPS (diluted)$2.59+1,195%

Balance sheet

See full
Cash & equivalents$488.4M+45.1%
Total debt$66.5M-2.7%
Total equity$473.1M+107%
Total assets$1.1B+32.9%

Cash flow

See full
Operating cash flow$34.5M+75.5%
CapEx$15.5M+14.0%
Free cash flow$19.0M—

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$4.16B+98.7%
Enterprise value$3.74B+105%
P/E21.8×-37.2×
P/S6.9×+2.1×

Profitability

See full
Gross margin59.9%+0.6pp
Operating margin17.9%+9.4pp
Net margin31.4%+23.4pp
FCF margin22.1%—

Returns & leverage

See full
Return on equity54.2%+34.8pp
Debt / equity0.1×-0.2×
Current ratio7.1×-1.2×

Segments

By product

See full
Liver Product$127.6M+43.4%
Heart Product$29.9M+6.4%
Lung Product$2.2M-36.6%

By segment

See full
Ocs Transplant Revenue$159.7M+32.5%

FAQ

When did TransMedics Group, Inc. report Q4 2025 earnings?
TransMedics Group, Inc. (TMDX) reported Q4 2025 earnings on February 24, 2026 after market close.
What were TransMedics Group, Inc.'s Q4 2025 revenue and EPS?
TransMedics Group, Inc. reported revenue of $160.8M and eps of $0.57 for Q4 2025.
Did TransMedics Group, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $155.4M by $5.4M. EPS beat the consensus estimate of $0.41 by $0.16.
How did TransMedics Group, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 32.2% from $121.6M a year earlier and eps grew 200.0% from $0.19.
Where can I find TransMedics Group, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-066953) and the 10-K periodic report (0001193125-26-067032) directly on SEC EDGAR. The filing index links above go to sec.gov.